Clinica Baviera ( (ES:CBAV) ) just unveiled an update.
Clinica Baviera, S.A. has announced its remuneration policy for directors, which will be proposed for approval at the next General Shareholders’ Meeting for the period 2025-2028. The policy, which maintains the structure of the previous one, emphasizes a balance between fixed and variable remuneration components to align with the company’s long-term objectives and reduce exposure to excessive risks.
More about Clinica Baviera
Clinica Baviera, S.A. operates in the healthcare industry, focusing on providing ophthalmology services. The company is based in Madrid and is a listed public limited company.
YTD Price Performance: 14.78%
Average Trading Volume: 9,194
Technical Sentiment Signal: Strong Sell
Current Market Cap: €593.4M
For an in-depth examination of CBAV stock, go to TipRanks’ Stock Analysis page.